DermaSensor
Miami
About DermaSensor
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions for potential cancer in seconds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $51.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: dermasensor.com.au
- Phone: 4153220838
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Primary and Urgent Care
Social Profiles
Canonical: https://fsome.com/organization/dermasensor-60740 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.